Skip to main content
Atrás
Watch Compare

BiomX Inc.

Calidad de datos: 83%
PHGE
NYSE Manufacturing Chemicals
$2.99
▲ $0.09 (3.10%)
Cap. Mercado: 19.57 M
Precio
$2.99
Cap. Mercado
19.57 M
Rango del Día
$2.50 — $3.00
Rango de 52 Semanas
$1.50 — $14.71
Volumen
119,428
Apertura $2.85
Promedio 50D / 200D
$5.25
43.10% below
Promedio 50D / 200D
$6.95
56.98% below

Quick Summary

Puntos Clave

Negative free cash flow of -26.39 M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-244.21%
Below sector avg (-51.02%)
ROIC-124.25%
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio1.70
Interest Coverage-48.78

Valoración

PE (TTM)
-0.54
Above sector avg (-1.98)
P/B Ratio1.87
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (44 pares)
Métrica Acción Mediana del Sector
P/E -0.5 -2.0
P/B 1.9 5.1
ROE % -244.2 -51.0
Net Margin % — -150.2
Rev Growth 5Y % — 9.3
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -36.20 M
ROE -244.21% ROA -112.74%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -26.39 M
ROIC -124.25% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1.70
Interest Coverage -48.78 Asset Turnover N/A
Working Capital 3.64 M Tangible Book Value 10.49 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.54 Forward P/E N/A
P/B Ratio 1.87 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -134.89%
Market Cap 19.57 M Enterprise Value 12.64 M
Per Share
EPS (Diluted TTM) 22.19 Revenue / Share N/A
FCF / Share -4.03 OCF / Share -4.03
EPS CAGR (1Y) 560.42% EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 72.91%
SBC-Adj. FCF -29.01 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -36.20 M -17.73 M -26.17 M -28.32 M -36.23 M
EPS (Diluted) 22.19 3.36 0.51 0.95 —
Gross Profit — — — — —
Operating Income -41.47 M -44.52 M -25.35 M -27.22 M -35.46 M
EBITDA — — — — —
R&D Expenses 21.29 M 24.66 M 16.70 M 16.24 M 22.68 M
SG&A Expenses — — — — —
D&A — — 871,000.0 2.52 M 986,000.0
Interest Expense 850,000.0 850,000.0 2.40 M 2.07 M 983,000.0
Income Tax 7,000.0 13,000.0 23,000.0 65,000.0 67,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 5.78 M 43.23 M 25.03 M 45.53 M 77.99 M
Total Liabilities — — — — —
Shareholders' Equity -1.30 M 24.15 M 3.08 M 21.04 M 47.54 M
Total Debt — 5.40 M 11.19 M 15.00 M 15.00 M
Cash & Equivalents 4.36 M 16.86 M 14.91 M 31.33 M 62.10 M
Current Assets 5.58 M 20.52 M 17.63 M 36.88 M 66.64 M
Current Liabilities 6.38 M 8.27 M 11.18 M 7.94 M 11.04 M